TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

221 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

126 studies on the map

Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis — The University of Texas Health Science Center at San Antonio, San AntonioA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) — Mayo Clinic in Arizona, ScottsdaleA Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) — University of Alabama at Birmingham, BirminghamNeurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD — Emory Clinic, AtlantaOutcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus — Arizona Kidney Disease and Hypertension Center, PhoenixTranscutaneous Auricular Vagus Nerve Stimulation Device in CKD Population — NYU Langone Health, New YorkEffect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1) — Brigham Women's Hospital, BostonLumbar Vein Embolization for Chronic Headaches With Nutcracker Physiology — Mayo Clinic Florida, JacksonvilleThe Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease — Brigham and Women's Hospital, BostonA Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. — Research Site, SurprisePrecision Medicine Approaches to Renal Osteodystrophy — Washington University in St. Louis (WashU), St LouisCommunityRx-Kidney Health — Goshen Medical Center, BeulavilleCSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes — VA Long Beach Healthcare System, Long Beach, CA, Long BeachEffect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD — Washington DC Veterans Affairs Medical Center (688), Washington D.C.Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease — Cleveland Clinic, ClevelandKidney Health: Eat Well, Live Well — Harris Health System's Outpatient Center, HoustonAcute Equol Supplementation and Vascular Function in Women With and Without CKD — University of Colorado Anschutz Medical Campus, AuroraA Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD) — SouthCoast Research Center, Inc., MiamiSafety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD) — Mayo Clinic, JacksonvilleThe Use of AR / VR in Patients Presenting to the ED With Renal Colic — Rutgers Robert Wood Johnson Barnabas Health Community Medical Center, Toms RiverHome Hospital for Suddenly Ill Adults — Brigham and Women's Hospital, BostonA Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis — Childrens Hospital of Los Angeles, Los AngelesDissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors — Scripps Green Hospital, San DiegoMechanism of SGLT2 Inhibition in the Kidney — University of Michigan, Ann ArborA Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function — Floridian Clinical Research, LLC, Miami LakesA Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease — Research Site, DecaturDuke APOL1 Research Biorepository — Duke University Medical Center, DurhamKidney Precision Medicine Project — University of Arizona, TucsonA Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART) — Shena Gazaway, BirminghamVirtual Reality in End Stage Kidney Disease — University of Pennsylvania, PhiladelphiaOpen-label Extension Study of Zigakibart in Adults With IgA Nephropathy. — Colorado Kidney Care Nephrology, DenverEndoForce Post Approval Study — MUSC Health Orangeburg, OrangeburgAnti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine — Brigham and Women's Hospital, BostonFeasibility of Breathwork Intervention With Older Adults After Knee Surgery — The University of Arizona, TucsonEvaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients. — University of Illinois at Chicago, ChicagoStaged Kidney Transplantation During Combined Heart/Kidney Transplantation — Cedars-Sinai Medical Center, Los AngelesConcomitant Renal and Urinary Bladder Allograft Transplantation — Mayo Clinic, RochesterPreoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial — Stanford University, StanfordDecellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry — Infirmary Heath, MobileFeasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease — Ann & Robert H. Lurie Children's Hospital of Chicago, ChicagoSotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease — Stanford University Medical Center, StanfordMaturation of Arteriovenous Fistula With Automated Sonography Assessments Trial — Trinity Research Group, DothanImplementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) — University of Alabama, BirminghamSPYRAL GEMINI Pilot Study — Stanford Hospital and Clinics, StanfordStudy to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD — Northwestern Memorial Hospital, ChicagoInspiratory Muscle Strength Training in Chronic Kidney Disease — University of Colorado - Anschutz Medical Campus, AuroraBone in CKD Alkali Response (BICARb Pilot Trial) — Albert Einstein College of Medicine, The BronxPhosphate Assessment in Chronic Kidney Disease Patients Study — University of Texas Southwestern Medical Center, DallasFeasibility of The Health Integrated Nutrition and Kidney Wellness Program — UPMC Kidney Clinic - Wexford, PittsburghPharmacy-led Transitions of Care Intervention to Improve Medication Adherence — University of Tennessee Medical Center, KnoxvilleCAPABLE Transplant — Johns Hopkins School of Nursing, BaltimoreCooperative Assessment of Late Effects for SCD Curative Therapies — Children's National Medical Center, Washington D.C.Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease — Brigham and Women's Hospital, BostonTestosterone Treatment in Men With Chronic Kidney Disease — Saint Louis Univeristy, St LouisSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease — Quotient Sciences Sea View, MiamiInspire HER: Inspiring the Heart and Emotions for Radical Health — University of Alabama at Birmingham, BirminghamPost Market Study for VasQ, an External Support Implant for Arteriovenous Fistula — Fresenius Vascular Care Long Beach, Long BeachSAfety of Regional Citrate Anticoagulation (SARCA Study) — John L. McClellan Memorial Veterans' Hospital, Little RockTechnology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients — UNM, AlbuquerqueChronic Kidney Disease-Education (CKD-EDU) — UR Medicine Nephrology - Strong West, BrockportEASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Apogee Clinical Research, HuntsvilleBehavioral AI to Predict and Increase Peritoneal Dialysis Uptake — Dallas Renal Group, DallasThe KidneyCARE (Community Access to Research Equity) Study — Geisinger Clinic, DanvillePatient-driven Management of BP in CKD — Iowa City VA Health Care System, Iowa City, IA, Iowa CityStudy to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD — New York University Langone Health, New YorkA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort — Research Site, GlendaleFood and Fitness With Medicine (FFWM) — Ohio State Healthy Community Center, ColumbusDirect to Patient Minimal Risk Biospecimen and Data Collection Research — Joined Bio, LexingtonBZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants — Ohio State University Comprehensive Cancer Center, ColumbusRaDIANT Health Systems Intervention — Piedmont Transplant Institute, AtlantaA Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease — Floridian Clinical Research, Miami LakesComparing Surgical and Endovascular Arteriovenous Fistula Creation — UCLA Division of Vascular and Endovascular Surgery Clinic, Los AngelesAPOL1 Genetic Testing in African Americans — SSM Health Saint Louis University Hospital, St LouisKidney Function in People With Cystic Fibrosis in the Era of HEMT — University of Alabama at Birmingham, BirminghamThe Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity — University of Mississippi Medical Center, JacksonPrevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias — Mayo Clinic, RochesterRoutine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD) — University of Missouri-Columbia, ColumbiaBreakthrough - T1DM and Chronic Kidney Disease — The University of Chicago, ChicagoModa-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants — North America Research Institute, San DimasEffects of Replacing High Protein Foods in People With Chronic Kidney Disease — Purdue University, West LafayetteNon-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health. — Clindove Research LLC, BrooklynInteractive Computer-adaptive Chronic Kidney Disease Education Program — University of Chicago Medical Center, ChicagoIntensive Patient Referral and Education Program Prior to Renal Replacement Therapy — University of Chicago Medical Center, ChicagoPatient Preference for Subcutaneous vs. Intravenous Immune Therapy — UPMC Hillman Cancer Center, PittsburghPReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis — MedStar Washington Hospital Center, Washington D.C.Pivotal Study of the Velocity™ pAVF System — Trinity Research Group, DothanREgulatory T Cell Therapy to Achieve Immunosuppression REduction — Mayo Clinic in Arizona, PhoenixCardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment — Fountains Family Care, ChandlerKidney Transplant Improvement Through New Exercise Training to Increase Capacity — Perelman Center for Advanced Medicine, PhiladelphiaPhysical Activity in CKD — Children's Hospital of Philadelphia, PhiladelphiaSymptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease — Mass General Brigham, BostonEquol and Vascular Function in Women With Chronic Kidney Disease — University of Colorado Anschutz Medical Campus, AuroraExercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength — Rocky Mountain Regional VA Medical Center, Aurora, CO, AuroraAK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring — Central Jersey Kidney Care - Hypertension & Nephrology Associates, EatontownA Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia — R1 Therapeutics Clinical Trial Site, HuntsvilleProteogenomic Monitoring and Assessment of Kidney Transplant Recipients — Northwestern University, ChicagoRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford — Sanford Health, Sioux FallsSympatholysis in Chronic Kidney Disease — Atlanta VA Medical Center, DecaturA Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) — Memorial Healthcare System, HollywoodGlucagon-Like Peptide-1 Receptor Agonist in ADPKD — University of Colorado - Anschutz Medical Campus, AuroraShingrix in Renal Transplant Recipients — University of Colorado Anschutz, AuroraIntravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis — Boston Medical Center, BostonA Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China — Renal Consultants Medical Group, Granada HillsPost-market Surveillance Study of the BD® WavelinQ™ EndoAVF System — California Institute of Renal Research, La JollaFeasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL) — University of Kansas Medical Center, Kansas CityPediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) — Wake Forest Health Sciences, Winston-SalemSolv Multi-Pass Hemodialysis System In-Center Clinical Study — Carolina Nephrology, GreenvilleRutgers University Study of the Genetics of Kidney Disease — Rutgers, The State University of New Jersey, PiscatawayFeasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program — Virginia Commonwealth University, RichmondCollaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease — Emory University Hospital Midtown, AtlantaStudy of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma — Stanford, Palo AltoA Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities — Unity Health Care, Washington D.C.A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease — N America Res Inst - San Dimas, San DimasIncremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets) — VA Long Beach Healthcare System, Long Beach, CA, Long BeachStudy to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease — Apogee Clinical Research, LLC, HuntsvilleDelayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants — UCLA, Los AngelesA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure — Research Site, FairhopeAn Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease — UI Health/University of Illinois Chicago, ChicagoEnhancing Physical Function in Older Adults With Chronic Kidney Disease — Wake Forest University Health Sciences, Winston-SalemAdia Med of Winter Park LLC Chronic Kidney Disease Research Study — Adia Med Of Winter Park, Winter ParkA Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006) — Panax Clinical Research ( Site 0003), Miami LakesDrug Interaction Potential of Pro-Inflammatory Conditions — Indiana University Hospital, IndianapolisDeceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage — Vanderbilt University Medical Center, NashvilleTransformative Research in Diabetic Nephropathy 2.0 — Penn Presbyterian Medical Center, PhiladelphiaSafety and Efficacy of Empagliflozin in Hemodialysis — Brigham and Women's Hospital, BostonIncremental Hemodialysis: The TwoPlus Trial — University of Florida, Jacksonville

Showing the 150 nearest — narrow your filters for fewer, closer studies.